In this issue:
Improving the detection and management of kidney health in primary care
Kidney clinical trials recruiting in Australia
Positive phase 3 data suggest possibility of novel practice changing therapies:
DMX-200 efficacious in FSGS
Complement pathway inhibition promising for IgAN
Dapirolizumab pegol improves lupus disease activity
Iohexol plasma clearance measurement protocol standardisation
PBAC recommendations
PBS listings
Recent FDA approvals
October Red Socks Run supports people with kidney disease
PARASOL findings expected in October
Upcoming ERA Congresses
World Kidney Day – March 13, 2025
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)